MiR-302b as a Combinatorial Therapeutic Approach to Improve Cisplatin Chemotherapy Efficacy in Human Triple-Negative Breast Cancer

MiR-302b as a Combinatorial Therapeutic Approach to Improve Cisplatin Chemotherapy Efficacy in Human Triple-Negative Breast Cancer

<i>Introduction</i>: Chemotherapy is still the standard of care for triple-negative breast cancers (TNBCs). Here, we investigated miR-302b as a therapeutic tool to enhance cisplatin sensitivity in vivo and unraveled the molecular mechanism. <i>Material</i><i>s</i>...

Full description

Bibliographic Details
Main Authors: Alessandra Cataldo, Sandra Romero-Cordoba, Ilaria Plantamura, Giulia Cosentino, Alfredo Hidalgo-Miranda, Elda Tagliabue, Marilena V. Iorio
Format: Article
Language:English
Published: MDPI AG 2020-08-01
Series:Cancers
Subjects:
microRNAs
triple-negative breast cancer
cisplatin
drug response
Online Access:https://www.mdpi.com/2072-6694/12/8/2261

Internet

https://www.mdpi.com/2072-6694/12/8/2261

Similar Items